Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
BMC Nephrology|June 13, 2018
Anemia and mortality in patients with nondialysis-dependent chronic kidney diseaseHeide A Stirnadel-Farrant, Jiacong Luo, Lata Kler, et al.Journal of the American Society of Nephrology : JASN|May 22, 2004
Administration of parenteral iron and mortality among hemodialysis patientsHarold I Feldman, Marshall Joffe, Bruce Robinson, et al.Clinical Kidney Journal|October 5, 2019
Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposureStephen Caltabiano, Borut Cizman, Olivia Burns, et al.Kidney International Reports|June 14, 2019
Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions-A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)Heide A Stirnadel-Farrant, Angelo Karaboyas, Borut Cizman, et al.Kidney Medicine|October 22, 2020
Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling EraBorut Cizman, Helen T Smith, Rodrigo Refoios Camejo, et al.Clinical Kidney Journal|February 13, 2019
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney diseaseLouis Holdstock, Borut Cizman, Amy M Meadowcroft, et al.Clinical Kidney Journal|February 13, 2019
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysisAmy M Meadowcroft, Borut Cizman, Louis Holdstock, et al.American Journal of Nephrology|February 5, 2023
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)Iain C Macdougall, Amy M Meadowcroft, Allison Blackorby, et al.Kidney360|June 20, 2022
Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program ExperienceKirsten L Johansen, Anjali Acharya, Borut Cizman, et al.Kidney International|March 3, 2023
The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney diseaseKirsten L Johansen, Alexander R Cobitz, Ajay K Singh, et al.Pageof 3